#drug-prices

[ follow ]
#pharmaceutical-industry

For pharma, Trump vs. Harris is a showdown between two industry foes

Both Trump and Harris agree on the need for government action to reduce high drug prices in the U.S.

Drugmakers hiked prices for hundreds of drugs in early January

Drugmakers raised prices on 575 name-brand drugs at the beginning of the year, though median hikes are lower compared to previous years.

Denmark gets Novo Nordisk to lower Ozempic prices

Sanders calls out Novo Nordisk for high drug prices as Denmark faces cost crisis.

Chamber Says White House Announcement on Medicare Drug Prices Threatens Patient Access

The Biden Administration's drug price negotiation is criticized as mere price control rather than a genuine negotiation, adversely impacting patients.

White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly

Biden administration announces drug price reductions under Medicare, projecting $1.5 billion in savings for older Americans.

Bernie Sanders on What Americans Need to Understand About Big Pharma

Senator Bernie Sanders is preparing to grill the CEOs of three major pharmaceutical companies over high drug prices.
The median launch price of innovative prescription drugs has increased significantly in recent years, according to a report by the Senate HELP committee.

For pharma, Trump vs. Harris is a showdown between two industry foes

Both Trump and Harris agree on the need for government action to reduce high drug prices in the U.S.

Drugmakers hiked prices for hundreds of drugs in early January

Drugmakers raised prices on 575 name-brand drugs at the beginning of the year, though median hikes are lower compared to previous years.

Denmark gets Novo Nordisk to lower Ozempic prices

Sanders calls out Novo Nordisk for high drug prices as Denmark faces cost crisis.

Chamber Says White House Announcement on Medicare Drug Prices Threatens Patient Access

The Biden Administration's drug price negotiation is criticized as mere price control rather than a genuine negotiation, adversely impacting patients.

White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly

Biden administration announces drug price reductions under Medicare, projecting $1.5 billion in savings for older Americans.

Bernie Sanders on What Americans Need to Understand About Big Pharma

Senator Bernie Sanders is preparing to grill the CEOs of three major pharmaceutical companies over high drug prices.
The median launch price of innovative prescription drugs has increased significantly in recent years, according to a report by the Senate HELP committee.
morepharmaceutical-industry

Federal Trade Commission Sues Big Pharma Middlemen for Inflating Insulin Prices

The FTC is legally challenging major pharmacy benefit managers for inflating insulin prices and blocking patient access to cheaper drugs.
#kamala-harris

Is This Even Legal?!' Critics Slam Kamala Harris Over Vow to Snatch' Patents After Resurfaced Vid Goes Viral

Vice President Kamala Harris proposed seizing drug patents to lower costs, prompting significant backlash from critics labeling her a dictator.

Striking to Hear': Fox's Baier Says Some of Harris's Populist Economics Are Taken Straight From Trump

Kamala Harris's economic agenda reflects significant contrasts with Trump's, highlighting her belief in recovery and attempts to distance from Bidenomics.

Mark Cuban is lauding Kamala Harris for joining him in his big fight to lower prescription drug prices

Kamala Harris aims to lower drug prices by taking on pharmacy middlemen.

Is This Even Legal?!' Critics Slam Kamala Harris Over Vow to Snatch' Patents After Resurfaced Vid Goes Viral

Vice President Kamala Harris proposed seizing drug patents to lower costs, prompting significant backlash from critics labeling her a dictator.

Striking to Hear': Fox's Baier Says Some of Harris's Populist Economics Are Taken Straight From Trump

Kamala Harris's economic agenda reflects significant contrasts with Trump's, highlighting her belief in recovery and attempts to distance from Bidenomics.

Mark Cuban is lauding Kamala Harris for joining him in his big fight to lower prescription drug prices

Kamala Harris aims to lower drug prices by taking on pharmacy middlemen.
morekamala-harris

Harris-Walz ticket sharpens contrast with Trump-Vance on health care

Walz's selection highlights health care's significance in the upcoming election, reflecting urgent voter concerns over costs and abortion access.
#politics

A Biden-Harris Lovefest

Biden and Harris celebrated significant Medicare drug cost reductions, showcasing a rare victory for Democrats amidst ongoing challenges in the Senate.

Biden Tears Into Trump In First Rally With Kamala Harris Drops New Nickname

Biden and Harris focused on drug pricing policies at their joint rally, emphasizing their efforts against big pharma and lack of Republican support.

A Biden-Harris Lovefest

Biden and Harris celebrated significant Medicare drug cost reductions, showcasing a rare victory for Democrats amidst ongoing challenges in the Senate.

Biden Tears Into Trump In First Rally With Kamala Harris Drops New Nickname

Biden and Harris focused on drug pricing policies at their joint rally, emphasizing their efforts against big pharma and lack of Republican support.
morepolitics
#medicare

U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations

The Biden administration is negotiating drug prices for Medicare, potentially saving seniors and taxpayers billions.

White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly

The Biden administration has negotiated lower prices for 10 high-cost Medicare drugs, potentially saving taxpayers and older Americans billions.

If You're on Medicare, You Could Save Money on Drugs This Year

Prescription drug costs are falling for more than a million seniors due to the Inflation Reduction Act signed by President Biden.
The changes include a $35 monthly cap on insulin costs, an out-of-pocket cap of $3,300, and the ability for Medicare to negotiate drug prices.

Patients see first savings from Biden's drug price push, as pharma lines up its lawyers

Patients are facing high drug costs, inspiring advocacy movements and legislative changes.
The 2022 Inflation Reduction Act signifies a significant step towards drug price reform, benefiting Medicare patients with cost reduction.

Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, Wegovy

Sen. Bernie Sanders investigating high drug prices for Ozempic and Wegovy.

U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations

The Biden administration is negotiating drug prices for Medicare, potentially saving seniors and taxpayers billions.

White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly

The Biden administration has negotiated lower prices for 10 high-cost Medicare drugs, potentially saving taxpayers and older Americans billions.

If You're on Medicare, You Could Save Money on Drugs This Year

Prescription drug costs are falling for more than a million seniors due to the Inflation Reduction Act signed by President Biden.
The changes include a $35 monthly cap on insulin costs, an out-of-pocket cap of $3,300, and the ability for Medicare to negotiate drug prices.

Patients see first savings from Biden's drug price push, as pharma lines up its lawyers

Patients are facing high drug costs, inspiring advocacy movements and legislative changes.
The 2022 Inflation Reduction Act signifies a significant step towards drug price reform, benefiting Medicare patients with cost reduction.

Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, Wegovy

Sen. Bernie Sanders investigating high drug prices for Ozempic and Wegovy.
moremedicare

Medicare negotiations for lower drug prices near the finish line

Medicare can now negotiate drug prices, benefiting seniors by potentially lowering costs for high-cost medications.

High price of popular diabetes drugs deprives low-income people of effective treatment

Supply shortages and insurance hurdles for GLP-1 agonists due to high drug prices lead to affordability issues for patients with diabetes and obesity.
[ Load more ]